2 weeks Ago By Defense World Staff
B. Riley Wealth Advisors Inc. cut its stake in shares of Stryker Co.
( NYSE:SYK – Free Report ) by 15.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 24,396 shares of the medical technology company’s stock after selling 4,387 shares during the quarter.
B. Riley Wealth Advisors Inc.’s holdings in Stryker were worth $8,320,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also bought and sold shares of SYK. Koshinski Asset Management Inc. purchased a new position in Stryker in the first quarter worth $795,000.
Envestnet Portfolio Solutions Inc. boosted its holdings in shares of Stryker by 43.1% in the 1st quarter.
Envestnet Portfolio Solutions Inc. now owns 18,491 shares of the medical technology company’s stock worth $6,617,000 after purchasing an additional 5,565 shares in the last quarter. Norden Group LLC bought a new position in shares of Stryker during the 1st quarter valued at about $4,027,000.
International Assets Investment Management LLC purchased a new position in shares of Stryker during the 1st quarter valued at about $21,970,000. Finally, BI Asset Management Fondsmaeglerselskab A S lifted its position in Stryker by 38.5% in the 1st quarter.
BI Asset Management Fondsmaeglerselskab A S now owns 19,796 shares of the medical technology company’s stock worth $7,084,000 after buying an additional 5,502 shares during the last quarter. Hedge funds and other institutional investors own 77.09% of the company’s stock.
Insider Buying and Selling In other news, CFO Glenn S. Boehnlein sold 20,000 shares of Stryker stock in a transaction that occurred on Friday, August 2nd. The shares were sold at an average price of $333.
00, for a total transaction of $6,660,000.00. Following the completion of the transaction, the chief financial officer now directly owns 2,852 shares in the company, valued at $949,716.
The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website . In other Stryker news, VP M Kathryn Fink sold 7,347 shares of the firm’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $366.
98, for a total transaction of $2,696,202.06. Following the completion of the sale, the vice president now directly owns 10,042 shares in the company, valued at approximately $3,685,213.
16. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website . Also, CFO Glenn S.
Boehnlein sold 20,000 shares of the company’s stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $333.00, for a total transaction of $6,660,000.
00. Following the completion of the transaction, the chief financial officer now owns 2,852 shares in the company, valued at approximately $949,716. The disclosure for this sale can be found here .
Insiders sold a total of 220,068 shares of company stock worth $71,811,372 in the last three months. 5.90% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades Read Our Latest Report on Stryker Stryker Stock Performance Shares of SYK stock opened at $360.27 on Monday. The company has a quick ratio of 0.
95, a current ratio of 1.68 and a debt-to-equity ratio of 0.51.
Stryker Co. has a 52 week low of $249.98 and a 52 week high of $374.
63. The firm has a market capitalization of $137.29 billion, a price-to-earnings ratio of 41.
13, a PEG ratio of 2.78 and a beta of 0.91.
The stock has a fifty day moving average of $347.92 and a 200 day moving average of $342.96.
Stryker ( NYSE:SYK – Get Free Report ) last released its quarterly earnings results on Tuesday, July 30th. The medical technology company reported $2.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.
79 by $0.02. Stryker had a net margin of 16.
12% and a return on equity of 22.89%. The company had revenue of $5.
42 billion during the quarter, compared to the consensus estimate of $5.40 billion. During the same period in the prior year, the firm earned $2.
54 earnings per share. Stryker’s revenue was up 8.5% on a year-over-year basis.
As a group, research analysts expect that Stryker Co. will post 12 earnings per share for the current year. Stryker Dividend Announcement The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 31st.
Stockholders of record on Monday, September 30th will be issued a dividend of $0.80 per share. This represents a $3.
20 dividend on an annualized basis and a dividend yield of 0.89%. The ex-dividend date of this dividend is Monday, September 30th.
Stryker’s dividend payout ratio (DPR) is presently 36.53%. About Stryker ( Free Report ) Stryker Corporation operates as a medical technology company.
The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Further Reading Five stocks we like better than Stryker Dividend Screener: How to Evaluate Dividend Stocks Before Buying 3 Bargain Stocks Under $20 With Major Growth Potential How to Invest in Tech Stocks and Top Tech Stocks to Consider Top 5 ETFs to Own Now and Into 2025 Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index Watch These 3 Former Short-Squeeze Stocks for a Big Rally Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Stryker Co. ( NYSE:SYK – Free Report ). Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.
com's FREE daily email newsletter ..
